GGrantIndex
← Leaderboards

Reynold Alexander Panettieri

Rutgers Biomedical And Health Sciences

$65,091,349
Attributed
$69,307,560
Total exposure
30
Grants
22
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $14.1M · FY200525
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$101,350,568 · 32
AHRQ$1,629,500 · 1

By mechanism

P01$35,613,073 · 15
UL1$28,851,093 · 1
UM1$11,270,857 · 1
P50$9,146,431 · 3
R01$8,642,998 · 6
U01$4,443,596 · 1

Top collaborators

Most similar at Rutgers Biomedical And Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Asthma

Research focus

AsthmaMolecularProgramsRespiratory Smooth MuscleResearch PersonnelMediatingAgonistBronchodilationSignal TransductionCouplingLaboratoriesBronchoconstrictionResponseTranslational ResearchG-Protein-Coupled ReceptorsSignal PathwayAirway HyperresponsivenessInflammationPreventLungCellsPathway InteractionsMuscle ContractionBase

Grant awards (116)

NJ ACTS: A Platform for Translational Science in New Jersey$5,567,259
UM1 · FY2025 · TR · contact PI
Administrative Core$814,750
P30 · FY2025 · HS · contact PI
ABCC1 mediates b2AR effects on excitation-contraction (E-C) coupling of human airway smooth muscle$350,960
P01 · FY2025 · HL · contact PI
Human Cell and Tissue Acquisition Core$350,960
P01 · FY2025 · HL · contact PI
NJ ACTS: A Platform for Translational Science in New Jersey$5,703,598
UM1 · FY2024 · TR · contact PI
Administrative Core$814,750
P30 · FY2024 · HS · contact PI
New Jersey Alliance for Clinical Translational Science: NJ ACTS$4,008,685
UL1 · FY2023 · TR · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$2,298,636
P01 · FY2023 · HL · contact PI
Project 1 - TGF-beta1 directly modulates excitation-contraction signaling in airway smooth muscle to evoke airway hyperresponsiveness in asthma$515,102
P01 · FY2023 · HL · contact PI
Core B - Human Cell/Tissue Acquisition and Physiology Care$271,442
P01 · FY2023 · HL · contact PI
Administrative Core$130,555
P01 · FY2023 · HL · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$60,161
P01 · FY2023 · HL · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$35,186
P01 · FY2023 · HL · contact PI
New Jersey Alliance for Clinical Translational Science: NJ ACTS$4,026,590
UL1 · FY2022 · TR · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$2,298,636
P01 · FY2022 · HL · contact PI
Rutgers Optimizes Innovation (ROI) Program$999,999
U01 · FY2022 · HL · contact PI
Project 1 - TGF-beta1 directly modulates excitation-contraction signaling in airway smooth muscle to evoke airway hyperresponsiveness in asthma$515,102
P01 · FY2022 · HL · contact PI
Core B - Human Cell/Tissue Acquisition and Physiology Care$271,442
P01 · FY2022 · HL · contact PI
Administrative Core$130,555
P01 · FY2022 · HL · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$76,612
P01 · FY2022 · HL · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$60,161
P01 · FY2022 · HL · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$55,918
P01 · FY2022 · HL · contact PI
New Jersey Alliance for Clinical Translational Science: NJ ACTS$4,648,239
UL1 · FY2021 · TR · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$2,298,636
P01 · FY2021 · HL · contact PI
New Jersey Alliance for Clinical Translational Science: NJ ACTS$1,200,946
UL1 · FY2021 · TR · contact PI
Rutgers Optimizes Innovation (ROI) Program$999,999
U01 · FY2021 · HL · contact PI
Project 1 - TGF-beta1 directly modulates excitation-contraction signaling in airway smooth muscle to evoke airway hyperresponsiveness in asthma$515,102
P01 · FY2021 · HL · contact PI
Rutgers Optimizes Innovation (ROI) Program$443,600
U01 · FY2021 · HL · contact PI
New Jersey Alliance for Clinical Translational Science: NJ ACTS$274,854
UL1 · FY2021 · TR · contact PI
Core B - Human Cell/Tissue Acquisition and Physiology Care$271,442
P01 · FY2021 · HL · contact PI
Administrative Core$130,555
P01 · FY2021 · HL · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$76,612
P01 · FY2021 · HL · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$55,467
P01 · FY2021 · HL · contact PI
New Jersey Alliance for Clinical Translational Science: NJ ACTS$4,640,627
UL1 · FY2020 · TR · contact PI
New Jersey Alliance for Clinical and Translational Science: NJ ACTS$3,792,941
UL1 · FY2020 · TR · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$2,290,948
P01 · FY2020 · HL · contact PI
New Jersey Alliance for Clinical Translational Science: NJ ACTS$1,482,000
UL1 · FY2020 · TR · contact PI
Rutgers Optimizes Innovation (ROI) Program$999,999
U01 · FY2020 · HL · contact PI
Project 1 - TGF-beta1 directly modulates excitation-contraction signaling in airway smooth muscle to evoke airway hyperresponsiveness in asthma$512,487
P01 · FY2020 · HL · contact PI
Core B - Human Cell/Tissue Acquisition and Physiology Care$270,319
P01 · FY2020 · HL · contact PI
Administrative Core$126,605
P01 · FY2020 · HL · contact PI
New Jersey Alliance for Clinical Translational Science: NJ ACTS$4,776,211
UL1 · FY2019 · TR · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$2,363,727
P01 · FY2019 · HL · contact PI
Rutgers Optimizes Innovation (ROI) Program$999,999
U01 · FY2019 · HL · contact PI
Project 1 - TGF-beta1 directly modulates excitation-contraction signaling in airway smooth muscle to evoke airway hyperresponsiveness in asthma$526,251
P01 · FY2019 · HL · contact PI
Core B - Human Cell/Tissue Acquisition and Physiology Care$284,216
P01 · FY2019 · HL · contact PI
Integrative Health Sciences Facility Core$225,681
P30 · FY2019 · ES · contact PI
Administrative Core$129,723
P01 · FY2019 · HL · contact PI
Development of an Oral Acidic Mammalian Chitinase Inhibitor to Treat Asthma$1,505,420
R44 · FY2018 · HL
Force phenotyping of airway smooth muscle cells to develop novel asthma therapies$234,750
R21 · FY2018 · EB
Integrative Health Sciences Facility Core$80,500
P30 · FY2018 · ES · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$2,435,478
P01 · FY2017 · HL · contact PI
Defining Steroid Inhibition of Beta2 Adrenergic Receptor Tolerance$484,109
P01 · FY2017 · HL · contact PI
Human Cell and Tissue Acquisition Core$308,918
P01 · FY2017 · HL · contact PI
Integrative Health Sciences Facility Core$280,000
P30 · FY2017 · ES · contact PI
Force phenotyping of airway smooth muscle cells to develop novel asthma therapies$209,125
R21 · FY2017 · EB
Administrative Core$123,860
P01 · FY2017 · HL · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$2,375,950
P01 · FY2016 · HL · contact PI
Defining Steroid Inhibition of Beta2 Adrenergic Receptor Tolerance$475,604
P01 · FY2016 · HL · contact PI
Human Cell and Tissue Acquisition Core$300,415
P01 · FY2016 · HL · contact PI
Development of an Oral Acidic Mammalian Chitinase Inhibitor to Treat Asthma$225,000
R44 · FY2016 · HL
Administrative Core$115,357
P01 · FY2016 · HL · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$59,528
P01 · FY2016 · HL · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$2,353,263
P01 · FY2015 · HL · contact PI
Defining Steroid Inhibition of Beta2 Adrenergic Receptor Tolerance$472,610
P01 · FY2015 · HL · contact PI
Human Cell and Tissue Acquisition Core$296,563
P01 · FY2015 · HL · contact PI
Integrative Health Sciences Facility Core$280,000
P30 · FY2015 · ES · contact PI
Administrative Core$112,360
P01 · FY2015 · HL · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$2,341,318
P01 · FY2014 · HL · contact PI
Defining Steroid Inhibition of Beta2 Adrenergic Receptor Tolerance$476,519
P01 · FY2014 · HL · contact PI
Human Cell and Tissue Acquisition Core$280,813
P01 · FY2014 · HL · contact PI
Administrative Core$116,271
P01 · FY2014 · HL · contact PI
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma$2,365,675
P01 · FY2013 · HL · contact PI
Defining Steroid Inhibition of Beta2 Adrenergic Receptor Tolerance$478,130
P01 · FY2013 · HL · contact PI
Human Cell and Tissue Acquisition Core$290,943
P01 · FY2013 · HL · contact PI
Administrative Core$117,720
P01 · FY2013 · HL · contact PI
RGS: A Molecular Switch Regulating Irreversible ASM Growth/Contraction in Asthma$490,194
R01 · FY2012 · HL · contact PI
RGS: A Molecular Switch Regulating Irreversible ASM Growth/Contraction in Asthma$498,742
R01 · FY2011 · HL · contact PI
RGS: A Molecular Switch Regulating Irreversible ASM Growth/Contraction in Asthma$504,105
R01 · FY2010 · HL · contact PI
RGS: A Molecular Switch Regulating Irreversible ASM Growth/Contraction in Asthma$559,927
R01 · FY2009 · HL · contact PI
Mechanisms of VEGF modulation of smooth muscle function$344,098
R01 · FY2009 · HL · contact PI
CORE--Lung and Airway Disease$102,758
P30 · FY2009 · ES · contact PI
Ozone ALTERS Airway Smooth Muscle FUNCTION IN ASTHMA$441,843
R01 · FY2008 · HL · contact PI
Interferons Modulate Airway Smooth Muscle Growth$404,954
R01 · FY2008 · HL · contact PI
Mechanisms of VEGF modulation of smooth muscle function$344,098
R01 · FY2008 · HL · contact PI
CORE--Lung and Airway Disease$88,319
P30 · FY2008 · ES · contact PI
Ozone ALTERS Airway Smooth Muscle FUNCTION IN ASTHMA$450,860
R01 · FY2007 · HL · contact PI
Interferons Modulate Airway Smooth Muscle Growth$413,921
R01 · FY2007 · HL · contact PI
Mechanisms of VEGF modulation of smooth muscle function$343,461
R01 · FY2007 · HL · contact PI
Mechanisms Regulation Functions of Airway Smooth Muscle$338,145
R01 · FY2007 · HL · contact PI
CORE--Lung and Airway Disease$81,286
P30 · FY2007 · ES · contact PI
Ozone ALTERS Airway Smooth Muscle FUNCTION IN ASTHMA$464,326
R01 · FY2006 · HL · contact PI
Interferons Modulate Airway Smooth Muscle Growth$427,086
R01 · FY2006 · HL · contact PI
CORE--Lung and Airway Disease$50,720
P30 · FY2006 · ES · contact PI
AIRWAY SMOOTH MUSCLE MODULATES INFLAMMATION IN ASTHMA$1,866,784
P50 · FY2005 · HL
Ozone ALTERS Airway Smooth Muscle FUNCTION IN ASTHMA$452,685
R01 · FY2005 · HL
Interferons Modulate Airway Smooth Muscle Growth$452,496
R01 · FY2005 · HL
Core--Murine studies$346,007
P50 · FY2005 · HL
Synthetic responses of human airway smooth muscle$346,007
P50 · FY2005 · HL
THE EFFECT OF EXPECTENCY ON SALMETEROL REVERSAL OF AIRWAY OBSTRUCTION IN ASTHMA$13,634
M01 · FY2005 · RR
AIRWAY SMOOTH MUSCLE MODULATES INFLAMMATION IN ASTHMA$2,039,422
P50 · FY2004 · HL
The Effect of Expectancy on Salmeterol Reversal of Airway Obstruction in Asthma$5,327
M01 · FY2004 · RR
AIRWAY SMOOTH MUSCLE MODULATES INFLAMMATION IN ASTHMA$1,980,319
P50 · FY2003 · HL
MECHANISMS REGULATING AIRWAY MUSCLE GROWTH$277,375
R01 · FY2003 · HL
AIRWAY SMOOTH MUSCLE MODULATES INFLAMMATION IN ASTHMA$1,925,920
P50 · FY2002 · HL
Core--Murine studies$320,986
P50 · FY2002 · HL
Synthetic responses of human airway smooth muscle$320,986
P50 · FY2002 · HL
MECHANISMS REGULATING AIRWAY MUSCLE GROWTH$277,375
R01 · FY2002 · HL
MECHANISMS REGULATING FUNCTIONS OF AIRWAY SMOOTH MUSCLE$133,430
R01 · FY2002 · HL
AIRWAY SMOOTH MUSCLE MODULATES INFLAMMATION IN ASTHMA$1,958,151
P01 · FY2001 · HL
MECHANISMS REGULATING AIRWAY MUSCLE GROWTH$277,375
R01 · FY2001 · HL
MECHANISMS REGULATING FUNCTIONS OF AIRWAY SMOOTH MUSCLE$133,430
R01 · FY2001 · HL
Core--Murine studies$0
P01 · FY2001 · HL
Synthetic responses of human airway smooth muscle$0
P01 · FY2001 · HL
MECHANISMS REGULATING FUNCTIONS OF AIRWAY SMOOTH MUSCLE$335,697
R01 · FY2000 · HL
MECHANISMS REGULATING AIRWAY MUSCLE GROWTH$277,375
R01 · FY2000 · HL